Tian Jin Bohai Chemical Co (600800) Fair Value & Analysis
Industrials · CN · Market cap 4.1B CNY
Analysis
Tian Jin Bohai Chemical Co (600800) currently trades at ¥3.47, while our model-based Fair Value estimate is ¥4.54 — implying the stock looks roughly 30.8% undervalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Tian Jin Bohai Chemical Co.,Ltd. engages in the production and sale of propylene and its by-products in China. The company offers propylene and hydrogen; pharmaceutical packaging, pharmaceutical instructions, food packaging, tobacco and alcohol packaging, textbooks, magazines, bank drafts, acceptance bills, bank checks, national bonds and other securities as well as various anti-counterfeiting bills, passbooks, freight waybills, air transport vouchers, medical bills, boarding passes, paper parking cards, insurance policies, invoices, tickets and non-carbon carbon paper bank documents; and data card products such as second generation ID card element layer, social security card, social card, bank card, and other cards. It also engages in new materials businesses; provision of technical services; and supporting terminal, payment identification terminal, system software, mobile terminal software, and Iot terminals and software. The company was formerly known as Tianjin Global Magnetic C…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.